MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the treatment of atherosclerotic lesions in native coronary arteries. This is the fourth breakthrough […]

InfoQuest Limited

4 มี.ค. 64

Medical expert warns thousands could die from HPV programming interrupted by Covid-19

On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also calling for global vaccine equity. One woman dies from cervical cancer every 2 minutes but HPV […]

InfoQuest Limited

4 มี.ค. 64

Cipla receives final approval for generic version of GlaxoSmithKline’s IMITREX® (Sumatriptan Nasal Spray, 20 mg)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Food and Drug Administration (U.S. FDA). Cipla’s Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic […]

InfoQuest Limited

3 มี.ค. 64

New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines

MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial findings from the CLOCK-MS vaccine sub-study show protective influenza antibody levels at four weeks post-vaccination in MS patients taking MAVENCLAD In both studies, protective antibody […]

InfoQuest Limited

1 มี.ค. 64

Think You’ve Been Harmed by Products Containing Talc? Your Rights May Be Affected and Your Injury Claims May Be Eliminated. Your Vote Will Help Determine How Injury Claims are Treated

Submit Your Vote by March 25, 2021. The following statement is being issued by Prime Clerk LLC regarding the Imerys Chapter 11. If you have a Talc Personal Injury Claim, your rights are affected by an upcoming vote on a plan of reorganization (the “Plan”) as part of the chapter 11 proceedings of Imerys Talc […]

InfoQuest Limited

1 มี.ค. 64

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial). PRELIEVE is a prospective, multicenter, open-label, non-randomized pilot study that evaluates the results of AFR implantation in patients with either heart […]

InfoQuest Limited

25 ก.พ. 64

New FDI World Dental Federation global survey reveals that two-thirds of countries are not allowing dentists to administer COVID-19 vaccines

Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups FDI World Dental Federation today called for more countries to enable dentists to administer COVID-19 vaccines after a survey of its members revealed the small number of countries currently permitted to do so. The survey was facilitated by […]

InfoQuest Limited

25 ก.พ. 64

Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A

Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. “Simoctocog Alfa (Nuwiq®) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the […]

InfoQuest Limited

24 ก.พ. 64
1 2 3 11